GRIFFIN KNEPP: Open Payments
NPI 1245951094 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 26 payments from 9 companies in 2025. Trend: 2023 $932 · 2024 $772 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $364 |
| Boston Scientific Corporation | 8 | $164 |
| Kestra Medical Technology Services, Inc. | 2 | $157 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| PFIZER INC. | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: FARXIGA, Assure WCD, EkoSonic, LOKELMA, JARDIANCE, Kerendia, ELIQUIS, WATCHMAN FLX.
Industry payments across KY — which companies pay providers there.
